CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for SR Biotek Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

SR Biotek Inc
B101, SICOX Tower, 484
Dunchon-daero, Jungwon-gu
Phone: +82 317263134p:+82 317263134 SEONGNAM, 13229  South Korea Ticker: 270210270210
Business Summary
SR biotek Inc. is a Korea-based company principally engaged in the manufacture and distribution of cosmetics. The Company distributes its products under brand name RAPHITOX and IDENEL LINE. The Company distributes its products within domestic market and to overseas markets.
(Source: N-30D)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2844 Perfumes, cosmetics, and other toilet preparations

General Information
Number of Employees: 20 (As of 12/31/2023)
Outstanding Shares: 1,655,205 (As of 7/5/2024)
Shareholders: 63
Stock Exchange: KON
Fax Number: +82 317332145


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024